Genome-Wide/NN
Association/NN
Study/NN
of/IN
Liver/JJ
Enzymes/NNS
in/IN
Korean/JJ
Children/NN
./.
====================
Liver/RB
enzyme/NN
elevations/NNS
,/,
as/IN
an/DT
indicator/NN
of/IN
liver/NN
function/NN
,/,
are/VBP
widely/RB
associated/VBN
with/IN
metabolic/JJ
diseases/NNS
./.
====================
Genome-wide/NN
population-based/JJ
association/NN
studies/NNS
have/VBP
identified/VBN
a/DT
genetic/JJ
susceptibility/NN
to/TO
liver/NN
enzyme/NN
elevations/NNS
and/CC
their/PRP$
related/JJ
traits/VBZ
;/:
however/RB
,/,
the/DT
genetic/JJ
architecture/NN
in/IN
childhood/NN
remains/VBZ
largely/RB
unknown/JJ
./.
====================
We/PRP
performed/VBD
a/DT
genome-wide/JJ
association/NN
study/NN
to/TO
identify/VB
new/JJ
genetic/JJ
loci/NNS
for/IN
liver/NN
enzyme/NN
levels/NNS
in/IN
a/DT
Korean/JJ
childhood/NN
cohort/NN
(/(
n/NN
=/JJ
484/CD
)/)
./.
====================
We/PRP
observed/VBD
three/CD
novel/JJ
loci/NNS
(/(
rs4949718/NN
,/,
rs80311637/NN
,/,
and/CC
rs596406/NN
)/)
that/WDT
were/VBD
multiply/RB
associated/VBN
with/IN
elevated/JJ
levels/NNS
of/IN
alanine/NN
transaminase/NN
and/CC
aspartate/NN
transaminase/NN
./.
====================
Although/IN
there/EX
are/VBP
some/DT
limitations/NNS
,/,
including/VBG
genetic/JJ
power/NN
,/,
additional/JJ
replication/NN
and/CC
functional/JJ
characterization/NN
will/MD
support/VB
the/DT
clarity/NN
on/IN
the/DT
genetic/JJ
contribution/NN
that/DT
the/DT
ST6GALNAC3/NN
,/,
ADAMTS9/NN
,/,
and/CC
CELF2/NN
genes/NNS
have/VBP
in/IN
childhood/NN
liver/NN
function/NN
./.
====================
Plasma/NN
liver/NN
enzyme/NN
tests/NNS
are/VBP
broadly/RB
applied/VBN
to/TO
predict/VB
biochemical/JJ
liver/NN
functions/NNS
and/CC
to/TO
diagnose/VB
liver/NN
diseases/NNS
./.
====================
Alanine/NN
transaminase/NN
(/(
ALT/NN
)/)
and/CC
aspartate/NN
transaminase/NN
(/(
AST/NN
)/)
are/VBP
closely/RB
associated/VBN
with/IN
hepatocyte/NN
damage/NN
and/CC
steatosis/NN
,/,
including/VBG
non-alcoholic/JJ
fatty/JJ
liver/NN
disease/NN
(/(
NAFLD/NN
)/)
[/(
1/CD
]/)
./.
====================
Elevated/JJ
liver/NN
enzyme/NN
levels/NNS
,/,
as/IN
prospective/JJ
risk/NN
factors/NNS
,/,
have/VBP
been/VBN
reported/VBN
to/TO
be/VB
involved/VBN
in/IN
type/NN
2/CD
diabetes/NNS
and/CC
coronary/JJ
heart/NN
disease/NN
[/(
2/CD
,/,
3/CD
]/)
./.
====================
However/RB
,/,
alkaline/NN
phosphatase/NN
and/CC
gamma-glutamyltranspeptidase/NN
are/VBP
related/JJ
with/IN
biliary/JJ
,/,
cholestatic/JJ
,/,
and/CC
alcoholic/JJ
diseases/NNS
[/(
4/CD
]/)
./.
====================
Overweightedness/RB
in/IN
childhood/NN
or/CC
adolescence/NN
is/VBZ
persistent/JJ
in/IN
adulthood/NN
obesity/NN
and/CC
is/VBZ
closely/RB
associated/VBN
with/IN
adverse/JJ
health/NN
effects/NNS
,/,
including/VBG
metabolic/JJ
diseases/NNS
[/(
5/CD
]/)
./.
====================
A/DT
recent/JJ
cohort/NN
study/NN
in/IN
Korean/JJ
adolescents/NNS
has/VBZ
shown/VBN
strong/JJ
associations/NNS
of/IN
liver/NN
enzyme/NN
levels/NNS
with/IN
a/DT
cluster/NN
of/IN
metabolic/JJ
syndrome/NN
components/NNS
[/(
6/CD
]/)
./.
====================
Thus/RB
,/,
finding/NN
genetic/JJ
markers/NNS
of/IN
liver/NN
enzyme/NN
levels/NNS
in/IN
childhood/NN
would/MD
be/VB
important/JJ
for/IN
early/JJ
prediction/NN
of/IN
liver/NN
function/NN
and/CC
its/PRP$
related/JJ
disease/NN
in/IN
adulthood/NN
./.
====================
Liver/RB
enzyme/NN
levels/NNS
are/VBP
affected/VBN
by/IN
environmental/JJ
and/CC
genetic/JJ
factors/NNS
./.
====================
The/DT
heritabilities/NNS
of/IN
liver/NN
enzyme/NN
levels/NNS
range/NN
from/IN
approximately/RB
35/CD
%/NN
to/TO
61/CD
%/NN
[/(
7/CD
,/,
8/CD
]/)
./.
====================
To/TO
date/NN
,/,
two/CD
genome-wide/JJ
association/NN
studies/NNS
(/(
GWASs/NNS
)/)
in/IN
European/JJ
ancestry/NN
populations/NNS
have/VBP
identified/VBN
genetic/JJ
variants/NNS
located/JJ
in/IN
multiple/JJ
genes/NNS
associated/VBN
with/IN
levels/NNS
of/IN
ALT/NN
(/(
HSD17B13-MAPK10/NN
,/,
TRIB1/NN
,/,
CHUK/NN
,/,
and/CC
SAMM50/NN
)/)
,/,
AST/NN
(/(
NBPF3-ALPL/NN
)/)
,/,
and/CC
both/CC
of/IN
them/PRP
(/(
CPN1/NN
and/CC
PNPLA3/NN
)/)
[/(
9/CD
,/,
10/CD
]/)
./.
====================
In/IN
addition/NN
,/,
a/DT
meta-analysis/NN
identified/VBN
pleiotropic/JJ
effects/NNS
between/IN
NAFLD/NN
and/CC
metabolic/JJ
traits/VBZ
,/,
such/JJ
as/IN
low-density/JJ
lipoprotein/NN
,/,
high-density/JJ
lipoprotein/NN
,/,
triglyceride/NN
,/,
fasting/VBG
glucose/NN
,/,
and/CC
insulin/NN
resistance/NN
[/(
11/CD
]/)
./.
====================
Despite/IN
the/DT
identification/NN
of/IN
novel/JJ
genes/NNS
or/CC
loci/NNS
associated/VBN
with/IN
liver/NN
enzymes/NNS
in/IN
cohort/JJ
populations/NNS
,/,
the/DT
common/JJ
variants/NNS
in/IN
childhood/NN
are/VBP
still/RB
largely/RB
unknown/JJ
./.
====================
Here/RB
,/,
we/PRP
present/VBP
findings/NNS
from/IN
a/DT
GWAS/JJ
in/IN
childhood/NN
subjects/NNS
to/TO
identify/VB
new/JJ
susceptibility/NN
loci/NNS
for/IN
liver/NN
enzyme/NN
levels/NNS
./.
====================
Study/NN
subjects/NNS
====================
Students/NNS
,/,
aged/JJ
between/IN
8/CD
and/CC
13/CD
years/NNS
,/,
were/VBD
recruited/VBN
from/IN
Gwacheon/JJ
City/NN
and/CC
Kyunggi/NNP
Province/NN
from/IN
April/NN
to/TO
June/JJ
2010/CD
./.
====================
This/DT
study/NN
was/VBD
performed/VBN
as/IN
a/DT
part/NN
of/IN
the/DT
Korean/JJ
Children-Adolescents/NNS
Study/NN
(/(
KoCAS/NN
)/)
,/,
which/WDT
has/VBZ
been/VBN
monitored/VBN
yearly/RB
since/IN
their/PRP$
entry/NN
into/IN
elementary/JJ
school/NN
at/IN
age/NN
7/CD
in/IN
Gwacheon/JJ
City/NN
or/CC
fourth/IN
grade/NN
at/IN
age/NN
10/CD
in/IN
Seoul/JJ
and/CC
Gyeonggi/NNP
Province/NN
,/,
Korea/NN
./.
====================
Subjects/NNS
who/WP
were/VBD
enrolled/VBN
in/IN
a/DT
specific/JJ
diet/NN
program/NN
or/CC
were/VBD
taking/VBG
any/DT
medications/NNS
known/VBN
to/TO
affect/VB
appetite/JJ
were/VBD
excluded/VBN
from/IN
the/DT
study/NN
./.
====================
AST/NN
and/CC
ALT/NN
levels/NNS
were/VBD
measured/VBN
in/IN
the/DT
serum/NN
of/IN
each/DT
subject/JJ
./.
====================
The/DT
study/NN
protocol/NN
was/VBD
approved/VBN
by/IN
the/DT
institutional/JJ
review/NN
board/JJ
of/IN
Seoul/JJ
Paik/NN
Hospital/JJ
,/,
Inje/NNP
University/NN
,/,
and/CC
the/DT
Korea/NN
Center/NN
for/IN
Disease/NN
Control/NN
and/CC
Prevention/NN
./.
====================
Informed/VBN
consent/NN
was/VBD
obtained/VBN
from/IN
the/DT
childrens/NNS
'/``
parents/NNS
./.
====================
Genotyping/VBG
and/CC
quality/NN
control/NN
====================
A/DT
total/JJ
of/IN
532/CD
samples/NNS
were/VBD
genotyped/VBN
using/VBG
the/DT
Illumina/NN
HumanOmni1-Quad/JJ
BeadChip/NN
(/(
Illumina/NN
Inc./NNP
,/,
San/JJ
Diego/NN
,/,
CA/NN
,/,
USA/NN
)/)
./.
====================
Samples/NNS
that/DT
revealed/VBD
the/DT
following/VBG
properties/NNS
were/VBD
excluded/VBN
:/:
genotyping/VBG
call/JJ
</JJR
98/CD
%/NN
,/,
heterozygosity/NN
>/JJR
30/CD
%/NN
,/,
sex/NN
inconsistency/NN
,/,
cryptic/JJ
first-degree/JJ
relative/JJ
,/,
or/CC
duplication/NN
./.
====================
A/DT
total/JJ
of/IN
48/CD
subjects/NNS
were/VBD
excluded/VBN
from/IN
the/DT
sample/NN
QC/NN
process/NN
./.
====================
Markers/NNS
with/IN
a/DT
high/JJ
missing/VBG
call/JJ
rate/NN
(/(
>/JJR
5/CD
%/NN
)/)
,/,
minor/JJ
allele/NN
frequency/NN
</JJR
0.01/CD
,/,
and/CC
significant/JJ
deviation/NN
from/IN
Hardy-Weinberg/JJ
equilibrium/NN
(/(
p/NN
</JJR
1/CD
×/NN
10-6/CD
)/)
were/VBD
also/RB
excluded/VBN
./.
====================
The/DT
remaining/VBG
747,076/CD
single/JJ
nucleotide/NN
polymorphisms/NNS
(/(
SNPs/NNS
)/)
were/VBD
used/VBN
in/IN
subsequent/JJ
analyses/NNS
for/IN
association/NN
./.
====================
Association/NN
analyses/NNS
====================
Genome-wide/NN
association/NN
was/VBD
analyzed/VBN
using/VBG
the/DT
PLINK/NN
software/JJ
(/(
http/NN
:/:
//pngu.mgh.harvard.edu/~purcell/plink/NN
)/)
./.
====================
The/DT
association/NN
between/IN
genotypes/NNS
and/CC
concentration/NN
of/IN
liver/NN
enzymes/NNS
in/IN
plasma/NN
was/VBD
evaluated/VBN
with/IN
linear/JJ
regression/NN
analysis/NN
,/,
controlling/VBG
for/IN
age/NN
and/CC
body/NN
mass/NN
index/NN
(/(
BMI/NN
)/)
as/IN
covariates/VBZ
./.
====================
The/DT
Manhattan/JJ
plots/NNS
of/IN
-log10/CD
(/(
p-value/NN
)/)
were/VBD
made/VBN
using/VBG
Haploview/NN
v./FW
4.2/CD
./.
====================
The/DT
quantile-quantile/JJ
plots/NNS
were/VBD
generated/VBN
using/VBG
R/NN
statistics/NNS
package/NN
to/TO
assess/VB
the/DT
overall/JJ
significance/NN
of/IN
the/DT
genome-wide/NN
associations/NNS
./.
====================
A/DT
total/JJ
of/IN
747,076/CD
SNP/NN
genotype/NN
assays/NNS
were/VBD
tested/VBN
on/IN
the/DT
DNA/NN
samples/NNS
of/IN
484/CD
Korean/JJ
childhood/NN
subjects/NNS
./.
====================
ALT/NN
and/CC
AST/NN
levels/NNS
of/IN
the/DT
subjects/NNS
according/VBG
to/TO
age/NN
and/CC
sex/NN
are/VBP
presented/VBN
in/IN
Supplementary/JJ
Table/JJ
1/CD
./.
====================
Linear/JJ
regression/NN
analyses/NNS
were/VBD
performed/VBN
to/TO
estimate/VB
the/DT
p-values/NNS
for/IN
the/DT
association/NN
between/IN
genotype/NN
distributions/NNS
and/CC
levels/NNS
of/IN
ALT/NN
and/CC
AST/NN
./.
====================
Manhattan/JJ
plots/NNS
of/IN
association/NN
analyses/NNS
of/IN
all/DT
SNPs/NNS
with/IN
respect/NN
to/TO
ALT/NN
and/CC
AST/NN
are/VBP
presented/VBN
with/IN
the/DT
chromosomal/JJ
positions/NNS
(/(
X-axis/NN
)/)
and/CC
negative/JJ
logarithm/NN
of/IN
p-values/NNS
(/(
Y-axis/NN
)/)
of/IN
each/DT
SNP/NN
(/(
Fig/NN
./.
====================
1/CD
)/)
./.
====================
Quantile-quantile/JJ
plots/NNS
comparing/VBG
the/DT
association/NN
p-values/NNS
with/IN
those/DT
expected/VBN
for/IN
a/DT
null/JJ
distribution/NN
are/VBP
also/RB
presented/VBN
(/(
Fig/NN
./.
====================
2/CD
)/)
./.
====================
The/DT
highest-ranked/JJ
SNPs/NNS
showing/VBG
the/DT
lowest/JJS
p-values/NNS
(/(
p/NN
</JJR
1.0/CD
×/CD
10-5/CD
)/)
of/IN
association/NN
with/IN
ALT/NN
and/CC
AST/NN
levels/NNS
are/VBP
listed/VBN
in/IN
Table/JJ
1/CD
./.
====================
In/IN
addition/NN
,/,
genotype/NN
clusters/NNS
of/IN
the/DT
SNPs/NNS
are/VBP
presented/VBN
in/IN
Supplementary/JJ
Fig/NN
./.
====================
1/CD
./.
====================
Although/IN
there/EX
was/VBD
no/DT
SNP/NN
satisfying/JJ
the/DT
criteria/NNS
of/IN
genome-wide/NN
significance/NN
(/(
p/NN
</JJR
1.0/CD
×/CD
10-8/CD
)/)
,/,
we/PRP
identified/VBD
three/CD
loci/NNS
(/(
rs4949718/NN
,/,
rs80311637/NN
,/,
and/CC
rs596406/NN
in/IN
ST6GALNAC3/NN
,/,
ADAMTS9/NN
,/,
and/CC
CELF2/NN
,/,
respectively/RB
)/)
that/WDT
were/VBD
suggestively/RB
associated/VBN
with/IN
levels/NNS
of/IN
ALT/NN
and/CC
AST/NN
./.
====================
Of/IN
these/DT
SNPs/NNS
,/,
rs4949718/NN
was/VBD
found/VBN
to/TO
be/VB
more/RBR
strongly/RB
associated/VBN
with/IN
ALT/NN
levels/NNS
(/(
p/NN
=/JJ
1.87/CD
×/CD
10-7/CD
)/)
but/CC
less/RBR
in/IN
AST/NN
levels/NNS
(/(
p/NN
=/JJ
1.49/CD
×/CD
10-6/CD
)/)
./.
====================
The/DT
missense/NN
rs80311637/NN
(/(
V1597M/NN
)/)
and/CC
intronic/JJ
rs596406/NN
SNPs/NNS
were/VBD
more/RBR
strongly/RB
associated/VBN
with/IN
an/DT
increased/VBN
risk/NN
of/IN
AST/NN
than/IN
ALT/NN
./.
====================
The/DT
levels/NNS
of/IN
ALT/NN
and/CC
AST/NN
,/,
known/VBN
as/IN
transaminases/VBZ
,/,
are/VBP
important/JJ
indicators/NNS
for/IN
determining/VBG
hepatocyte/NN
injury/NN
or/CC
hepatocellular/JJ
diseases/NNS
./.
====================
However/RB
,/,
ALT/NN
is/VBZ
known/VBN
to/TO
be/VB
found/VBN
in/IN
the/DT
highest/JJS
level/NN
in/IN
the/DT
liver/NN
;/:
thus/RB
,/,
ALT/NN
levels/NNS
are/VBP
more/RBR
liver-specific/JJ
indicators/NNS
[/(
4/CD
]/)
./.
====================
Moreover/RB
,/,
it/PRP
has/VBZ
been/VBN
reported/VBN
that/IN
ALT/NN
levels/NNS
are/VBP
more/RBR
significantly/RB
associated/VBN
with/IN
a/DT
cluster/NN
of/IN
metabolic/JJ
syndrome/NN
than/IN
AST/NN
levels/NNS
in/IN
a/DT
Korean/JJ
adolescent/JJ
cohort/NN
study/NN
[/(
6/CD
]/)
./.
====================
In/IN
this/DT
study/NN
,/,
we/PRP
identified/VBD
three/CD
novel/JJ
genes/NNS
(/(
ST6GALNAC3/NN
,/,
ADAMTS9/NN
,/,
and/CC
CELF2/NN
)/)
that/WDT
were/VBD
multiply/RB
associated/VBN
with/IN
elevated/JJ
levels/NNS
of/IN
ALT/NN
and/CC
AST/NN
./.
====================
Of/IN
the/DT
three/CD
loci/NNS
,/,
rs4949718/NN
in/IN
the/DT
intron/NN
region/NN
of/IN
ST6GALNAC3/NN
yielded/VBD
the/DT
lowest/JJS
p-value/NN
for/IN
the/DT
association/NN
with/IN
ALT/NN
,/,
compared/VBN
to/TO
AST/NN
levels/NNS
(/(
Table/JJ
1/CD
)/)
./.
====================
In/IN
addition/NN
,/,
rs80311637/NN
(/(
ADAMTS9/NN
)/)
and/CC
rs596406/NN
(/(
CELF2/NN
)/)
were/VBD
shown/VBN
to/TO
be/VB
more/RBR
strongly/RB
associated/VBN
with/IN
AST/NN
levels/NNS
,/,
compared/VBN
to/TO
ALT/NN
./.
====================
These/DT
results/NNS
indicate/VBP
that/IN
the/DT
liver-specific/JJ
feature/NN
of/IN
ALT/NN
was/VBD
not/RB
driven/VBN
as/IN
the/DT
secondary/JJ
association/NN
for/IN
AST/NN
./.
====================
In/IN
recent/JJ
,/,
a/DT
previous/JJ
GWAS/NN
in/IN
an/DT
Amish/JJ
population/NN
identified/VBD
two/CD
genetic/JJ
variants/NNS
(/(
rs17209512/NN
and/CC
deletion/NN
)/)
in/IN
glutamic-oxaloacetic/JJ
transaminase/NN
1/CD
(/(
GOT1/NN
)/)
that/WDT
were/VBD
associated/VBN
with/IN
serum/NN
AST/NN
./.
====================
However/RB
,/,
the/DT
rs17209512/NN
SNP/NN
,/,
which/WDT
is/VBZ
in/IN
incomplete/JJ
LD/NN
with/IN
rs76850691/NN
,/,
was/VBD
not/RB
replicated/VBN
in/IN
our/PRP$
study/NN
(/(
Table/JJ
1/CD
)/)
./.
====================
For/IN
the/DT
three/CD
multiply/RB
associated/VBN
loci/NNS
,/,
we/PRP
performed/VBD
conditional/JJ
analyses/NNS
to/TO
test/VB
whether/IN
the/DT
association/NN
with/IN
the/DT
other/JJ
trait/JJ
was/VBD
simply/RB
secondary/JJ
to/TO
the/DT
primary/JJ
association/NN
(/(
Supplementary/JJ
Table/JJ
2/CD
)/)
./.
====================
In/IN
these/DT
analyses/NNS
,/,
the/DT
association/NN
signals/NNS
on/IN
rs4949718/NN
for/IN
AST/NN
and/CC
rs80311637/NN
and/CC
rs596406/NN
for/IN
ALT/NN
were/VBD
abolished/VBN
by/IN
adjustment/JJ
of/IN
the/DT
ALT/NN
and/CC
AST/NN
,/,
respectively/RB
./.
====================
It/PRP
is/VBZ
assumed/VBN
that/IN
the/DT
multiple/JJ
effects/NNS
of/IN
these/DT
loci/NNS
on/IN
ALT/NN
and/CC
AST/NN
resulted/VBD
from/IN
the/DT
secondary/JJ
effects/NNS
by/IN
physiologically/RB
correlated/VBD
features/NNS
between/IN
ALT/NN
and/CC
AST/NN
[/(
12/CD
]/)
./.
====================
In/IN
addition/NN
,/,
when/WRB
comparing/VBG
with/IN
BMI-unadjusted/JJ
data/NNS
,/,
the/DT
association/NN
signals/NNS
in/IN
ALT/NN
were/VBD
relatively/RB
weaker/JJR
than/IN
those/DT
of/IN
the/DT
BMI-adjusted/JJ
data/NNS
./.
====================
However/RB
,/,
there/EX
was/VBD
no/DT
significant/JJ
difference/NN
in/IN
p-values/NNS
before/IN
and/CC
after/IN
adjusting/VBG
for/IN
BMI/NN
in/IN
AST/NN
(/(
data/NNS
not/RB
shown/VBN
)/)
./.
====================
ST6GALNAC3/NN
encodes/VBZ
a/DT
type/NN
of/IN
sialyltransferase/NN
that/DT
plays/VBZ
a/DT
role/NN
in/IN
the/DT
transfer/NN
of/IN
sialic/JJ
acids/NNS
from/IN
cytidine/JJ
5/CD
'/``
monophospho-N-acetylneuraminic/JJ
acid/NN
(/(
CMP-NeuAc/NN
)/)
to/TO
the/DT
carbohydrate/JJ
termini/NNS
of/IN
glycoproteins/NNS
and/CC
glycolipids/NNS
[/(
13/CD
]/)
./.
====================
Previous/JJ
GWASs/NNS
have/VBP
revealed/VBN
the/DT
associations/NNS
of/IN
ST6GALNAC3/NN
SNPs/NNS
with/IN
human/JJ
electroencephalogram/NN
and/CC
nicotine/NN
dependence/NN
[/(
14/CD
,/,
15/CD
]/)
;/:
however/RB
,/,
there/EX
has/VBZ
been/VBN
no/DT
report/NN
on/IN
an/DT
association/NN
with/IN
liver/NN
enzyme/NN
levels/NNS
./.
====================
Although/IN
the/DT
association/NN
with/IN
liver/NN
enzymes/NNS
is/VBZ
still/RB
unknown/JJ
,/,
ST6GALNAC3/NN
has/VBZ
been/VBN
shown/VBN
to/TO
be/VB
associated/VBN
with/IN
subscapular/JJ
skin-fold/JJ
thickness/DT
,/,
a/DT
type/NN
of/IN
obesity-related/VBN
trait/VBP
,/,
in/IN
a/DT
Korean/JJ
adult/JJ
population/NN
[/(
16/CD
]/)
./.
====================
Obesity/NN
affects/VBZ
elevated/JJ
liver/NN
enzyme/NN
levels/NNS
by/IN
inducing/VBG
inflammatory/JJ
responses/NNS
in/IN
the/DT
liver/NN
,/,
accompanied/VBN
by/IN
increases/VBZ
in/IN
C-reactive/JJ
protein/NN
[/(
17/CD
]/)
./.
====================
The/DT
involvements/NNS
between/IN
obesity/NN
and/CC
liver/NN
enzyme/NN
levels/NNS
have/VBP
been/VBN
found/VBN
in/IN
cohort/NN
studies/NNS
[/(
18-20/CD
]/)
./.
====================
Therefore/RB
,/,
the/DT
association/NN
of/IN
ST6GALNAC3/NN
with/IN
obesity/NN
may/MD
influence/VB
liver/NN
enzyme/NN
levels/NNS
indirectly/RB
./.
====================
In/IN
addition/NN
,/,
ST6GALNAC3/NN
protein/NN
interacts/VBZ
with/IN
α2-Heremans-Schmid/NN
glycoprotein/NN
(/(
AHSG/NN
)/)
,/,
which/WDT
is/VBZ
also/RB
known/VBN
as/IN
fetuin-A/JJ
,/,
by/IN
enzyme-substrate/NN
specificity/NN
[/(
13/CD
]/)
./.
====================
AHSG/NN
is/VBZ
abundantly/RB
distributed/VBN
in/IN
serum/NN
protein/NN
and/CC
is/VBZ
produced/VBN
mainly/RB
in/IN
the/DT
liver/NN
,/,
and/CC
elevated/JJ
levels/NNS
of/IN
this/DT
protein/NN
are/VBP
associated/VBN
with/IN
the/DT
risk/NN
of/IN
NAFLD/NN
[/(
21/CD
]/)
./.
====================
Considering/VBG
that/DT
liver/NN
enzyme/NN
levels/NNS
are/VBP
closely/RB
involved/VBN
indicators/NNS
in/IN
NAFLD/NN
[/(
22/CD
,/,
23/CD
]/)
,/,
the/DT
interaction/NN
with/IN
AHSG/NN
might/MD
induce/VB
an/DT
association/NN
between/IN
ST6GALNAC3/NN
and/CC
liver/NN
enzyme/NN
levels/NNS
./.
====================
ADAMTS9/NN
is/VBZ
a/DT
metalloproteinase/NN
that/DT
plays/VBZ
a/DT
role/NN
in/IN
cleavage/NN
of/IN
proteoglycans/NNS
and/CC
is/VBZ
expressed/VBN
in/IN
skeletal/JJ
muscle/NN
and/CC
pancreas/NN
[/(
24/CD
]/)
./.
====================
ADAMTS9/NN
has/VBZ
been/VBN
reported/VBN
as/IN
a/DT
type/NN
2/CD
diabetes/NNS
susceptibility/NN
region/NN
in/IN
a/DT
GWAS/JJ
[/(
24/CD
]/)
./.
====================
This/DT
gene/NN
has/VBZ
also/RB
shown/VBN
an/DT
association/NN
with/IN
insulin/NN
resistance/NN
and/CC
impaired/JJ
beta-cell/NN
function/NN
in/IN
the/DT
pancreas/NN
[/(
25/CD
]/)
./.
====================
Taken/VBN
together/RB
,/,
the/DT
association/NN
of/IN
ADAMTS9/NN
with/IN
liver/NN
enzymes/NNS
might/MD
be/VB
due/JJ
to/TO
its/PRP$
susceptibility/NN
to/TO
diabetes/NNS
and/CC
insulin/NN
resistance/NN
./.
====================
CELF2/NN
(/(
also/RB
known/VBN
as/IN
CUGBP2/NN
)/)
induces/VBZ
the/DT
skipping/NN
of/IN
exon/NN
11/CD
of/IN
insulin/NN
receptor/NN
(/(
IR/NN
)/)
./.
====================
The/DT
mRNA/NN
expression/NN
level/NN
of/IN
exon-skipped/JJ
IR/NN
is/VBZ
significantly/RB
lower/JJR
in/IN
liver/NN
than/IN
in/IN
other/JJ
organs/NNS
in/IN
mouse/NN
models/NNS
[/(
26/CD
]/)
./.
====================
It/PRP
has/VBZ
been/VBN
reported/VBN
that/IN
a/DT
decrease/NN
in/IN
the/DT
number/NN
of/IN
IRs/NNS
on/IN
target/NN
cells/NNS
can/MD
cause/VB
insulin/NN
resistance/NN
[/(
27/CD
]/)
./.
====================
Therefore/RB
,/,
it/PRP
is/VBZ
assumed/VBN
that/IN
CELF2/NN
affects/VBZ
liver/NN
enzyme/NN
levels/NNS
by/IN
lowering/VBG
expression/NN
of/IN
IR/NN
in/IN
liver/NN
that/DT
induces/VBZ
insulin/NN
resistance/NN
./.
====================
In/IN
summary/NN
,/,
our/PRP$
data/NNS
demonstrate/VBP
new/JJ
multiple/JJ
associations/NNS
with/IN
ALT/NN
and/CC
AST/NN
levels/NNS
in/IN
a/DT
Korean/JJ
childhood/NN
cohort/NN
./.
====================
Further/RB
replication/NN
and/CC
functional/JJ
studies/NNS
remain/VBP
to/TO
be/VB
done/VBN
to/TO
clarify/VB
the/DT
genetic/JJ
factors/NNS
of/IN
liver/NN
dysfunction/NN
./.
====================
Manhattan/JJ
plots/NNS
of/IN
association/NN
results/NNS
for/IN
alanine/NN
transaminase/NN
(/(
ALT/NN
)/)
and/CC
aspartate/NN
transaminase/NN
(/(
AST/NN
)/)
levels/NNS
./.
====================
Manhattan/JJ
plots/NNS
of/IN
the/DT
genome-wide/NN
analyses/NNS
of/IN
association/NN
with/IN
ALT/NN
(/(
A/DT
)/)
and/CC
AST/NN
(/(
B/NN
)/)
are/VBP
based/VBN
on/IN
a/DT
total/JJ
of/IN
484/CD
Korean/JJ
children/NN
./.
====================
Color/JJ
scale/NN
of/IN
X-axis/NN
represents/VBZ
chromosomes/NNS
,/,
and/CC
negative/JJ
logarithms/NNS
of/IN
p-values/NNS
are/VBP
shown/VBN
on/IN
the/DT
Y-axis/NN
./.
====================
Quantile-quantile/JJ
plots/NNS
of/IN
association/NN
results/NNS
for/IN
alanine/NN
transaminase/NN
(/(
ALT/NN
)/)
and/CC
aspartate/NN
transaminase/NN
(/(
AST/NN
)/)
levels/NNS
in/IN
Korean/JJ
children/NN
for/IN
747,076/CD
single/JJ
nucleotide/NN
polymorphisms/NNS
(/(
SNPs/NNS
)/)
./.
====================
Quantile-quantile/JJ
plots/NNS
for/IN
ALT/NN
(/(
A/DT
)/)
and/CC
AST/NN
(/(
B/NN
)/)
AST/NN
are/VBP
composed/VBN
of/IN
X-axis/NN
and/CC
Y-axis/NN
indicate/VBP
the/DT
negative/JJ
log-scale/JJ
of/IN
expected/VBN
p-values/NNS
of/IN
each/DT
SNP/NN
and/CC
the/DT
negative/JJ
log-scale/JJ
of/IN
the/DT
observed/VBN
p-values/NNS
,/,
respectively/RB
./.
====================
A/DT
straight/JJ
line/NN
indicates/VBZ
the/DT
expected/VBN
results/NNS
under/IN
Hardy-Weinberg/JJ
equilibrium/NN
./.
====================
Genetic/JJ
loci/NNS
associated/VBN
with/IN
levels/NNS
of/IN
ALT/NN
and/CC
AST/NN
at/IN
p/NN
</JJR
1/CD
×/NN
10-5/CD
in/IN
the/DT
GWAS/NN
of/IN
Korean/JJ
children/NN
(/(
n/NN
=/JJ
484/CD
)/)
====================
